Skip to main content
Medtronic plc logo

Medtronic plc — Investor Relations & Filings

Ticker · MDT ISIN · US58446C1036 LEI · D56MRZY2INAN94ZONZ37 US Manufacturing
Open in API
Filings indexed 1,143 across all filing types
Latest filing 2020-05-13 Capital/Financing Update
Country US United States of America
Listing US MDT

About Medtronic plc

https://www.medtronic.com/

Medtronic plc is a global healthcare technology company that develops, manufactures, and sells device-based medical therapies and solutions. The company's portfolio addresses more than 70 health conditions, primarily organized into four key areas: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Its products range from pacemakers and neurovascular care devices to insulin pumps and systems for robotic-assisted surgery. Medtronic's technologies are designed to be used by healthcare systems, physicians, clinicians, and patients to alleviate pain, restore health, and extend life.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 12, 2020, by Medtronic Public Limited Company. It reports the entry into a material definitive agreement, specifically a Term Loan Agreement involving a significant unsecured term loan. The content focuses on the details of the loan agreement, its terms, and related financial obligations. There are no financial statements or comprehensive financial performance data included, nor is this an earnings release or annual/interim report. The document is a current report disclosing a financing event, which aligns with the category of Capital/Financing Update (CAP). The document length is 6939 characters, which is sufficient to contain substantive information about the financing event rather than just an announcement or a brief notice. Therefore, the appropriate classification is CAP with high confidence.
2020-05-13 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the reporting period January 1 to December 31, 2019. It references Rule 13p-1 under the Securities Exchange Act and includes an exhibit which is the Conflict Minerals Report. The document length is 2735 characters, which is relatively short and primarily serves as a disclosure filing rather than a full report. Form SD filings are specialized regulatory disclosures and do not fit into categories like Annual Report, Interim Report, or Earnings Release. Given the nature of the filing and its regulatory context, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2020-05-01 English
PRIMARY DOCUMENT
Director's Dealing
2020-05-01 English
PRIMARY DOCUMENT
Director's Dealing
2020-05-01 English
PRIMARY DOCUMENT
Director's Dealing
2020-05-01 English
PRIMARY DOCUMENT
Director's Dealing
2020-05-01 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.